- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Glabellar Crease in United Kingdom
Total 7463 results
-
University of MichiganDamon Runyon Cancer Research FoundationCompletedBreast Cancer | Chronic PainUnited States
-
The University of Texas Health Science Center at...Completed
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Brazil, France, Slovenia, Spain, Taiwan, Japan, Italy, Argentina, India, Germany, Hungary, Russian Federation, Singapore, Ukraine, Costa Rica, Czechia, G... and more
-
National Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Triple-Negative Breast Carcinoma | Unresectable Solid NeoplasmUnited States
-
Stony Brook UniversityUnknownBreast Cancer | Breast Reconstruction | MastectomyUnited States
-
EVIVE BiotechnologyCompletedBreast Cancer | NeutropeniaUnited States
-
West Virginia UniversityCompletedObesity | Breast CancerUnited States
-
Surgical Innovation Associates, Inc.Active, not recruiting
-
Hoffmann-La RocheCompletedHER2-Positive Metastatic Breast Cancer | HER2-Negative Metastatic Breast Cancer | Locally Advanced or Early Breast CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingQuality of Life | Hodgkin Lymphoma | Non Hodgkin Lymphoma | Stage I Breast Cancer | Stage II Breast Cancer | Stage III Breast Cancer | Heart; Functional DisturbanceUnited States
-
University of Texas Southwestern Medical CenterAmerican Cancer Society, Inc.CompletedDepression | Breast Cancer | Physical ActivityUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Completed
-
University of WashingtonSchering-PloughCompletedSoft Tissue Sarcoma | Breast CancerUnited States
-
Beth Israel Deaconess Medical CenterRecruiting
-
PfizerTerminatedBreast CancerUnited States, Belgium, Hungary, China, Hong Kong, Poland, Singapore
-
Bristol-Myers SquibbTerminated
-
University of Illinois at Urbana-ChampaignCompletedBreast Cancer | Physical Activity | Mild Cognitive ImpairmentUnited States
-
Hefei TG ImmunoPharma Co., Ltd.RecruitingMelanoma | Colorectal Cancer | Ovarian Cancer | Triple Negative Breast CancerUnited States
-
Jazz PharmaceuticalsRecruitingMetastatic HER2-positive Breast CancerUnited States, Austria, Italy, Spain, France, United Kingdom, Japan, Germany, Belgium, Greece, Australia, Canada, Poland, Brazil, South Korea
-
Radionetics OncologyRecruitingLocoregionally Recurrent Hormone-receptor Positive Breast Cancer | Metastatic Hormone Receptor Positive Breast CancerUnited States, Australia
-
Kathy MillerCompletedCancer of the BreastUnited States
-
Bryan Schneider, MDHoosier Cancer Research Network; Walther Cancer Institute; Vera Bradley Foundation... and other collaboratorsCompletedBreast Cancer | Malignant Neoplasm of BreastUnited States
-
University of California, San FranciscoNovartisCompleted
-
Dana-Farber Cancer InstitutePfizerActive, not recruitingBreast CancerUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital and other collaboratorsTerminated
-
NCIC Clinical Trials GroupCompletedBreast CancerUnited States, Canada
-
SCRI Development Innovations, LLCBristol-Myers Squibb; BayerCompletedMetastatic Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedLung | Breast | Ovarian | Cervical | RenalUnited States
-
National Cancer Institute (NCI)RecruitingBreast Carcinoma | Breast Atypical Ductal Hyperplasia | Breast Atypical Lobular Hyperplasia | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In Situ | Estrogen Receptor-Positive Breast CarcinomaUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; Translational...CompletedBreast NeoplasmsUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerBelgium, Hungary, Spain, Argentina, Russian Federation, Sweden, Lebanon, Australia, Denmark, Ireland, United Kingdom, Thailand, Turkey, Peru, Brazil, Malaysia, India, United States
-
Genentech, Inc.CompletedBreast CancerUnited States, Korea, Republic of, Australia, Austria, Czechia, United Kingdom, Belgium, Spain
-
Wiseman Research Initiatives LLCTerminatedBreast Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Louisiana State University Health Sciences Center...Columbia UniversityCompletedBreast CancerUnited States
-
M.D. Anderson Cancer CenterTerminatedBreast CancerUnited States, Japan
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Completed
-
Memorial Sloan Kettering Cancer CenterPfizerTerminatedBreast Cancer | Tobacco DependenceUnited States
-
National Cancer Institute (NCI)CompletedBreast Neoplasm | Hereditary Neoplastic SyndromeUnited States
-
Ascentage Pharma Group Inc.SuspendedBreast Cancer | Solid Tumor, AdultUnited States, China
-
Avera McKennan Hospital & University Health CenterCompletedBreast Cancer | Ovarian CancerUnited States
-
European Organisation for Research and Treatment...Hoffmann-La Roche; UNICANCER; Janssen Diagnostics, LLC; SUCCESSCompletedBreast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Circulating Tumor CellsFrance, Germany, Belgium, United Kingdom
-
Yale UniversityJohns Hopkins University; Stemline Therapeutics, Inc.Recruiting
-
NCIC Clinical Trials GroupCompletedBreast CancerUnited States, Canada
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerUnited States, Korea, Republic of, Spain, Brazil, Taiwan, Germany, Russian Federation, Australia
-
Dilon Medical Technologies Ltd.Completed
-
Stanford UniversityNational Cancer Institute (NCI); Cummings FoundationCompleted
-
A&G Pharmaceutical Inc.University of Maryland Greenebaum Cancer CenterRecruitingNon Small Cell Lung Cancer | Mesothelioma | Triple Negative Breast Cancer | Hormone-Resistant Breast CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingObesity | Overweight | Ductal Breast Carcinoma In Situ | Deleterious BRCA1 Gene Mutation | Deleterious BRCA2 Gene Mutation | Premalignant LesionUnited States